Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -20.60% vs 9.79% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -8.93% vs 9,375.82% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -11.23% vs -18.09% in Mar 2025
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.39
23.99
-10.60
-44.19%
Share Warrants & Outstandings
Total Reserve
242.30
251.50
-9.20
-3.66%
Shareholder's Funds
276.17
275.48
0.69
0.25%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.88
-0.88
-100.00%
Secured Loans
0.00
0.86
-0.86
-100.00%
Unsecured Loans
0.00
0.02
-0.02
-100.00%
Deferred Tax Assets / Liabilities
4.44
-0.13
4.57
3,515.38%
Other Long Term Liabilities
6.59
2.34
4.25
181.62%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.18
0.00
1.18
0.00%
Total Non-Current Liabilities
12.21
2.55
9.66
378.82%
Current Liabilities
Trade Payables
11.58
19.71
-8.13
-41.25%
Other Current Liabilities
15.39
23.30
-7.91
-33.95%
Short Term Borrowings
0.00
0.53
-0.53
-100.00%
Short Term Provisions
1.32
0.00
1.32
0.00%
Total Current Liabilities
28.30
43.54
-15.24
-35.00%
Total Liabilities
316.68
321.58
-4.90
-1.52%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.62
93.74
-0.12
-0.13%
Less: Accumulated Depreciation
15.09
40.73
-25.64
-62.95%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
78.53
53.01
25.52
48.14%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
101.80
-101.80
-100.00%
Intangible assets under development
0.00
0.03
-0.03
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.65
10.56
-9.91
-93.84%
Other Non Current Assets
87.63
1.25
86.38
6,910.40%
Total Non-Current Assets
173.59
166.64
6.95
4.17%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
14.64
32.41
-17.77
-54.83%
Sundry Debtors
17.19
91.30
-74.11
-81.17%
Cash and Bank
106.12
20.10
86.02
427.96%
Other Current Assets
1.66
0.76
0.90
118.42%
Short Term Loans and Advances
3.47
10.37
-6.90
-66.54%
Total Current Assets
143.09
154.94
-11.85
-7.65%
Net Current Assets (Including Current Investments)
114.79
111.40
3.39
3.04%
Total Current Assets Excluding Current Investments
143.09
154.94
-11.85
-7.65%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
316.68
321.58
-4.90
-1.52%
Contingent Liabilities
22.34
19.87
2.47
12.43%
Total Debt
0.00
0.34
-0.34
-100.00%
Book Value per share (adjusted)
41.01
114.84
-73.83
-64.29%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 6.59 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -20.60% vs 9.79% in Mar 2025
Annual - Fixed Assets
Fixed Assets 78.53 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -8.93% vs 9,375.82% in Mar 2025
Annual - Investments
Investments 0.00 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 143.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -11.23% vs -18.09% in Mar 2025






